174 related articles for article (PubMed ID: 24536040)
1. Health-related quality-of-life and treatment targets in myasthenia gravis.
Utsugisawa K; Suzuki S; Nagane Y; Masuda M; Murai H; Imai T; Tsuda E; Konno S; Nakane S; Suzuki Y; Fujihara K; Suzuki N
Muscle Nerve; 2014 Oct; 50(4):493-500. PubMed ID: 24536040
[TBL] [Abstract][Full Text] [Related]
2. [Clinical factors affecting quality of life and treatment targets in patients with myasthenia gravis].
Nagane Y
Rinsho Shinkeigaku; 2013; 53(11):1299-302. PubMed ID: 24291967
[TBL] [Abstract][Full Text] [Related]
3. The MG-QOL15 Japanese version: validation and associations with clinical factors.
Masuda M; Utsugisawa K; Suzuki S; Nagane Y; Kabasawa C; Suzuki Y; Shimizu Y; Utsumi H; Fujihara K; Uchiyama S; Suzuki N
Muscle Nerve; 2012 Aug; 46(2):166-73. PubMed ID: 22806364
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in 188 patients with myasthenia gravis in China.
Yang Y; Zhang M; Guo J; Ma S; Fan L; Wang X; Li C; Guo P; Wang J; Li H; Li Z
Int J Neurosci; 2016; 126(5):455-62. PubMed ID: 26000922
[TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis: sleep quality, quality of life, and disease severity.
Martínez-Lapiscina EH; Erro ME; Ayuso T; Jericó I
Muscle Nerve; 2012 Aug; 46(2):174-80. PubMed ID: 22806365
[TBL] [Abstract][Full Text] [Related]
6. Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study.
Nagane Y; Murai H; Imai T; Yamamoto D; Tsuda E; Minami N; Suzuki Y; Kanai T; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Aoki M; Utsugisawa K
BMJ Open; 2017 Feb; 7(2):e013278. PubMed ID: 28235967
[TBL] [Abstract][Full Text] [Related]
7. Construct and concurrent validation of the MG-QOL15 in the practice setting.
Burns TM; Grouse CK; Conaway MR; Sanders DB;
Muscle Nerve; 2010 Feb; 41(2):219-26. PubMed ID: 19941339
[TBL] [Abstract][Full Text] [Related]
8. The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers.
Barnett C; Katzberg H; Nabavi M; Bril V
J Clin Neuromuscul Dis; 2012 Jun; 13(4):201-5. PubMed ID: 22622164
[TBL] [Abstract][Full Text] [Related]
9. The modified rankin scale to assess disability in myasthenia gravis: Comparing with other tools.
Farrugia ME; Carmichael C; Cupka BJ; Warder J; Brennan KM; Burns TM
Muscle Nerve; 2014 Oct; 50(4):501-7. PubMed ID: 24639179
[TBL] [Abstract][Full Text] [Related]
10. Determinants of quality of life in Brazilian patients with myasthenia gravis.
Mourão AM; Gomez RS; Barbosa LS; Freitas Dda S; Comini-Frota ER; Kummer A; Lemos SM; Teixeira AL
Clinics (Sao Paulo); 2016 Jul; 71(7):370-4. PubMed ID: 27464292
[TBL] [Abstract][Full Text] [Related]
11. An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts.
Boldingh MI; Dekker L; Maniaol AH; Brunborg C; Lipka AF; Niks EH; Verschuuren JJ; Tallaksen CM
Health Qual Life Outcomes; 2015 Aug; 13():115. PubMed ID: 26232146
[TBL] [Abstract][Full Text] [Related]
12. Oral corticosteroid therapy and present disease status in myasthenia gravis.
Imai T; Suzuki S; Tsuda E; Nagane Y; Murai H; Masuda M; Konno S; Suzuki Y; Nakane S; Fujihara K; Suzuki N; Utsugisawa K
Muscle Nerve; 2015 May; 51(5):692-6. PubMed ID: 25155615
[TBL] [Abstract][Full Text] [Related]
13. Quality of life of myasthenia gravis patients.
Kulkantrakorn K; Jarungkiatkul W
J Med Assoc Thai; 2010 Oct; 93(10):1167-71. PubMed ID: 20973319
[TBL] [Abstract][Full Text] [Related]
14. Major motor-functional determinants associated with poor self-reported health-related quality of life in myasthenia gravis patients.
Cioncoloni D; Casali S; Ginanneschi F; Carone M; Veronica B; Rossi A; Giannini F
Neurol Sci; 2016 May; 37(5):717-23. PubMed ID: 27038315
[TBL] [Abstract][Full Text] [Related]
15. [Investigation and analysis of health-related quality of life in myasthenia gravis patients with myasthenia gravis quality of life-15 Chinese version].
Miao XH; Lian ZY; Liu J; Chen HX; Shi ZY; Zhou HY; Yang R
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):514-520. PubMed ID: 29930422
[TBL] [Abstract][Full Text] [Related]
16. Disease-specific measure of quality of life for myasthenia gravis.
Mullins LL; Carpentier MY; Paul RH; Sanders DB;
Muscle Nerve; 2008 Aug; 38(2):947-56. PubMed ID: 18697209
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between oral corticosteroid therapy and present disease status in myasthenia gravis].
Imai T
Rinsho Shinkeigaku; 2013; 53(11):1306-8. PubMed ID: 24291969
[TBL] [Abstract][Full Text] [Related]
18. Translation and validation of the arabic version of the revised 15-item myasthenia gravis quality-of-life questionnaire.
Alanazy MH; Abuzinadah AR; Muayqil T
Muscle Nerve; 2018 Apr; 57(4):581-585. PubMed ID: 28857210
[TBL] [Abstract][Full Text] [Related]
19. Fatigue, self-efficacy and psychiatric symptoms influence the quality of life in patients with myasthenia gravis in Tianjin, China.
Fan X; Xing C; Yang L; Wang J; Feng L
J Clin Neurosci; 2020 Sep; 79():84-89. PubMed ID: 33070925
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements.
Padua L; Evoli A; Aprile I; Caliandro P; Mazza S; Padua R; Tonali P
Neurol Sci; 2001 Oct; 22(5):363-9. PubMed ID: 11917973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
